Publikationen

Wissenschaftliche Publikationen

Copy Number Variation in the Compliment Factor H Related Genes and Age-Related Macular Degeneration
Kubista KE, Tosakulwong N, Wu Y, Ryu E, Roeder JL, Hecker LA, Baratz KH, Brown WL, Edwards AO.
Mol Vis 2011;17:2080-2092.
Comparing Treatment of Neovascular Age-Related Macular Degeneration with Sequential Intravitreal Avastin and Macugen versus Intravitreal Mono-Therapy – A Pilot Study
Schmid-Kubista KE, Krebs I, Ansari Shahrezaei S, Haas P, Hagen S, Binder S.
Curr Eye Res 2011;36:958-963.
Contribution of Copy Number Variation in the Regulation of Complement Activation Locus to Development of Age-Related Macular Degeneration
Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
Invest Ophthalmol Vis Sci 2009;50:5070-5079. Epub 2009 Jun 24.
Systemic Bevacizumab (Avastin®) Therapy for Exudative Neovascular Age-Related Macular Degeneration. The BEAT-AMD-Study
Schmid-Kubista KE, Krebs I, Gruenberger B, Zeiler F, Schueller J, Binder S
Br J Ophthalmol 2009;93:914-919. Epub 2009 Apr 29.
Effect of Work-Related Ultraviolet Exposition and Ophthalmic Changes in Austrian Farmers - The SVB-UV-Study
Schmid-Kubista KE, Kellner L, Felke S, Wanka A, El Modeir A, Schmidt JB, Cabaj A, Schmalwieser A, Rohn H, Stadelmann H, Spiess J, Fischer W, Hönigsmann H, Maier H, Binder S.
Ophthamic Res 2010;43:201-207.
Comparison of Macular Function and Visual Fields after Membrane Blue or Infracyanine Green Staining in Vitreoretinal Surgery
Schmid-Kubista KE, Lamar PD, Schenk A, Stolba U, Binder S.
Graefe's Arch Clin Exp Ophthalmol 2010;248:381-388. Epub 2009 Oct 13.
Daytime Levels of Melatonin in Patients with Age-Related Macular Degeneration
Schmid-Kubista KE, Glittenberg CG, Cezanne M, Holzmann K, Neumaier-Ammerer B, Binder S.
Acta Ophthalmol 2009;87:89-93. Epub 2008 May 20.
Extracorporal Rheohaemapheresis for Age Related Macular Degeneration: Preliminary Experience in 4 Patients
Schmid KE, Worel N, Höcker P, Binder S.
Spektrum der Augenheilkd 2007;21:240-242.
Update on Ocular Complications of Systemic Cancer Chemotherapy.
Schmid KE, Kornek GV, Scheithauer W, Binder S.
Surv Ophthalmol 2006;51:19-40.
Effect of Grid Laser Photocoagulation in Diffuse Diabetic Macular Edema in Correlation to Glycosylated Haemoglobin (HbA1c).
Schmid KE, Neumaier-Ammerer B, Stolba U, Binder S.
Graefe's Arch Clin Exp Ophthalmol 2006;244:1446-1452
Chemotherapeutische Nebenwirkungen im Augenbereich.
Schmid KE, Binder S.
Spektrum Augenheilkd 2005;19:210-220.
Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed.
Schmid KE, Kornek GV, Schüll B, Raderer M, Lenauer A, Depisch D, Lang F, Scheithauer W.
Onkologie 2003;26:255-258.
Circulating Angiopoietic Cells and Diabetic Retinopathy in T2DM Patients With and Without Macrovascular Disease.
Brunner S, Hoellerl F, Schmid-Kubista KE, Zeiler F, Schernthaner G, Binder S, Schernthaner GH.
Invest Ophthalmol Vis Sci 2011 Mar 11 [Epub ahead of print] (accepted 17.2.11)
Serum VEGF and CFH in Exudative Age-Related Macular Degeneration
Haas P, Steindl K, Aggermann T, Schmid-Kubista KE, Krugluger W, Hageman GS, Binder S.
Curr Eye Res 2011;36:143-148.
The E2-2 Protein and Fuchs Corneal Dystrophy
Baratz KH, Tosakulwong N, Ryu E, Brown WL, Branham K, Chen W, Schmid-Kubista KE, Heckenlively JR, Swaroop A, Abecasis G, Bailey KR, Edwards AO.
N Engl J Med 2010;363:1016-1024.
Functional Genomics of Systemic Complement Activation in Age-Related Macular Degeneration
Hecker LA, Edwards AO, Ryu E, Tosakulwong N, Baratz KH, Brown WL, Charbel Issa P, Scholl HP, Pollok-Kopp B, Schmid-Kubista KE, Bailey KR, Oppermann M.
Hum Mol Genet 2010;19:209-215.
Complement Factor H Gene Polymorphisms and Chlamydia pneumoniae Infection in Age-Related Macular Degeneration
Haas P, Steindl K, Schmid-Kubista KE, Aggermann T, Krugluger W, Hageman GS, Binder S.
Eye 2009;23:2228-2232.
Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy – First in Vivo Data
Brunner S, Schernthaner GH, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE, Zeiler F, Binder S, Schernthaner G.
Invest Ophthalmol Vis Sci 2009;50:392-398.
Foveal Thickness after Cataract Surgery – Measurement by Optical Coherence Tomography.
Neumaier-Ammerer B, Schmid-Kubista KE, Binder S.
Spektrum der Augeheilkd 2008;22/5:301-304.
Natural course of intraocular pressure after cataract surgery with sodium hyaluronate 1% (Healon) versus hydroxypropylmethylcellulose 2% (Ocucoat).
Rainer G, Schmid KE, Findl O, Sacu S, Kiss B, Heinzl H, Menapace R.
Ophthalmology 2007;114:1089-1093.
Natural Course of Intraocular Pressure after Cataract Surgery with Sodium Chondroitin Sulphate 4% - Sodium Hyaluronate 3% (Viscoat®).
Rainer G, Menapace R, Schmid KE, Sacu S, Kiss B, Heinze G, Findl O.
Ophthalmology 2005;112:1714-1718.
Optical Coherence Tomography Guided Retreatment of Photodynamic Therapy.
Krebs I, Binder S, Stolba U, Schmid K, Glittenberg C, Brannath W, Goll A.
Ophthalmol 2005;89:1184-1187.
Effect of a Fixed Dorzolamide-Timolol Combination on Intraocular Pressure after Small-Incision Cataract Surgery with Viscoat.
Rainer G, Menapace R, Findl O, Sacu S, Schmid K, Petternel V, Kiss B, Georgopoulos M.
J Cataract Refract Surg 2003;29:1748-1752.
Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer: Updated Results of a Randomized Multicenter Phase II Trial Comparing Two Different Dose Schedules.
Scheithauer W, Kornek GV, Raderer M, Schüll B, Schmid K, Kovats E, Schneeweiss B, Lang F, Lenauer A, Depisch D.
Recent Advances and Research Updates 2005;6:149-160.
Biweekly High Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Scheithauer W, Schüll B, Ulrich-Pur H, Schmid K, Raderer M, Haider K, Kwasny W, Depisch D, Schneeweiss B, Lang F, Kornek G.
Annals of Oncology 2003;14:97-104.
Amelioration of Docetaxel / Cisplatin Induced Polyneuropathy by Alphalipoic Acid.
Gedlicka C, Kornek GV, Schmid K, Scheithauer W.
Annals of Oncology 2003;14:339-343.
Irinotecan plus Raltitrexed versus Raltitrexed in Patients with Gemcitabine-Pretreated Advanced Pancreatic Adenocarcinoma.
Ulrich-Pur H, Raderer M, Kornek GV, Schüll B, Schmid K, Haider K, Kwasny W, Depisch D, Schneeweiss B, Lang F, Scheithauer W.
Br J Cancer 2003;88:1180-1184.
Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
Scheithauer W, Kornek GV, Schmid K, Raderer M, Lenauer A, Depisch D, Lang F, Schneeweiss B, Längle F.
J Clin Oncol 2003;2:1307-1312.
Effective Combination Chemotherapy with Bimonthly Docetaxel and Cisplatin with or without Hematopoetic Growth Factor Support in Patients with Advanced Gastroesophageal Cancer.
Schüll B, Kornek GV, Schmid K, Raderer M, Hejna M, Lenauer A, Depisch D, Lang F, Scheithauer W.
Oncology 2003;65:211-217.
Intermittent Weekly High-Dose Capecitabine in Combination with Oxaliplatin: A Phase I / II Study in First-Line Treatment of Patients with Advanced Colorectal Cancer.
Scheithauer W, Kornek G, Raderer M, Schüll B, Schmid K, Längle F, Huber H.
Annals of Oncology 2002;13:1583-1589.
Second-line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.
Schüll B, Kornek G, Schmid K, Raderer M, Ulrich-Pur H, Fiebiger W, Schneeweiss B, Lenauer A, Depisch D, Scheithauer W.
Onkologie 2002;25:358-362.

Dissertation

Natural Course of Postoperative IOP after Small Incision Cataract Surgery with Three Different Viscoelastic Substances
Betreuer: Findl O, Rainer G.
Prüfer: Menapace R, Findl O.

Zeitungsartikel

Strahlend schöner Augen-Blick
Kubista K.
NEWS Beauty Guide 23.2.2012:30-31.
Fall der Woche: Alexandra und ihre roten Punkte.
Kubista K.
ÄrzteMagazin 2011;12:20-23.
Augenschmerz nicht unterschätzen.
Kubista K.
Ärzte Woche 26.5.2011:29-30.
Population at Risk: Patients With Cancer – Therapy Complications
Kubista K.
Ocular Surgery News 2006;24:83-87.

Nationale und internationale Vortragstätigkeiten

Vorträge

Rheohemapheresis and Lutein Supplementation (Xantophyll Carotenoid) in the Non-Exudative Form of Age-Related Macular Degeneration |(ReLux-AMD)
Kubista KE, Worel N, Falkner-Radler CI, Hagen S, Leitner G, Hoecker P, Binder S.
8th International Society for Apharesis Congress (ISFA), September 2011, Wien.
Inflammatorisches Makulaödem - Update der Pathogenese und Therapie
Hochwarter A, Wimpissinger B, Schmid-Kubista KE, Binder S.
52. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Juni 2011, Mayerhofen im Zillertal
Augenschmerz nicht unterschätzen
Schmid-Kubista KE.
Schmerz Interdisziplinär, April 2011, Wien.
OCT in Retinal Detachment Surgery.
Neumaier-Ammerer B, Schmid-Kubista KE, Falkner-Radler CI, Binder S.
3rd Retina Science Day, Februar 2011, Wien.
Contribution of Copy Number Variation in the Regulation of Complement Activation Locus to Development of Age-Related Macular Degeneration.
Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
51. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2010, Zell am See.
Comparison of Combined Therapy of Intravitreal Injection of Avastin and Macugen versus Mono-therapy. The MAAM Study – a Pilot Study.
Schmid-Kubista KE, Krebs I, Ansari Shahrezaei S, Haas P, Hages S, Binder S.
ARVO Annual Meeting, Mai 2010, Fort Lauderdale.
Copy Number Variation in Regulation of Complement Activation Locus and the Development of AMD
Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
2nd Retina Science Day, Februar 2010, Wien.
Circulating Angiopoietic Cells in Type I and Type II Diabetic Patients with Various Stages of Retinopathy
Brunner S, Schernthaner GH, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE, Zeiler F, Schernthaner G, Binder S.
2nd Retina Science Day, Februar 2010, Wien
Copy Number Variation in the Regulation of Complement Activation Locus
Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
4th International Conference on Vitreoretinal Diseases, September 2009, Wien.
Functional Genomics Complement Activation in AMD
Edwards AO, Hecker LA, Ryu E, Tosakulwong N, Baratz KH, Brown WL, Charbel Issa P, Pollok-Kopp B, Schmid-Kubista KE, Bailey KR, Oppermann M.
4th International Conference on Vitreoretinal Diseases, September 2009, Wien
Circulating Angiopathic Cells in Various Forms of Diabetic Retinopathy
Brunner S, Schernthaner GH, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE, Zeiler F, Schernthaner G, Binder S.
4th International Conference on Vitreoretinal Diseases, September 2009, Wien.
Functional Genomics Complement Activation in AMD
Edwards AO, Hecker LA, Ryu E, Tosakulwong N, Baratz KH, Brown WL, Charbel Issa P, Pollok-Kopp B, Schmid-Kubista KE, Bailey KR, Oppermann M.
First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology, Juni 2009, Kreta.
Systemic Complement Activation Increases the Risk of Developing AMD
Hecker LA, Edwards AO, Ryu E, Baratz KH, Brown WL, Charbel Issa P, Scholl HPN, Pollok-Kopp B, Schmid-Kubista KE, Oppermann M.
ARVO Annual Meeting, Mai 2009, Fort Lauderdale.
Occupational UV-Exposure of Austrian Farmers
Elmodeir A, Schmalwieser A, Wanka A, Cabaj A, Schmid-Kubista K, Felke S, Kellner L, Rohn H, Spiess J, Fischer W, Binder S, Hönigsmann H, Maier H.
3rd Libyan Dermatology and Venereology Society Congress & 5th Maghrabian Congress, Oktober 2008, Sirte, Lebanon.
Membrane Blue versus Infracyanine Green Staining in Vitreoretinal Surgery.
Schmid-Kubista KE, Lamar PD, Schenk A, Stolba U, Binder S.
8th EURETINA Congress, May 2008, Vienna, Austria.
Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy – First in Vivo Data
Brunner S, Schernthaner G, Satler M, Schmid-Kubista KE, Binder S, Schernthaner G.
8th EURETINA Congress, May 2008, Vienna, Austria.
UV-Folgeschäden am Auge.
Schmid-Kubista KE, Kellner L.
AUVA-Veranstaltung, UV-Schutz bei Arbeiten im Freien, April 2008, Wien.
Einfluss der Blaulichtfilterintraokularlinsen auf den Melatoninspiegel bei der nicht-exsudativen Form der alterbedingten Makuladegeneration. (BluMel-Studie).
Schmid KE, Brunner S, Glittenberg CG, Holzmann K, Brannath W, Binder S.
Polytech Meeting, September 2006, Wien.
Neue Behandlungsmethoden bei der AMD.
Schmid KE.
Fortbildung für Pflegepersonal im Rahmen der 47. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2006, Stift Göttweig.
Daytime Levels of Melatonin in Patients with Age-Related Macular Degeneration.
Schmid KE, Glittenberg C, Cezanne M, Holzmann K, Zimmer R, Neumaier-Ammerer B, Binder S.
Invest. Ophthalmol. Vis. Sci. 2006 47: E-Abstract 5910. ARVO Annual Meeting, Mai 2006, Fort Lauderdale.
Systemische Therapien – ein Überblick
Schmid KE.
Neue systemische Behandlung der AMD, Ophthalmologische Fortbildung, Februar 2006, Wien.
Systemic Therapy in AMD.
Schmid KE, Krebs I, Binder S.
Innovations in Vitreous and Retinal Diseases, 3rd International Conference, September 2005, Wien.
Chemotherapeutische Nebenwirkungen im Augenbereich.
Schmid KE, Binder S.
45. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2004, Alpbach.

Poster

Copy Number Variation in Complement Factor H Related Genes and Age-Related Macular Degeneration
Schmid-Kubista KE, Tosakulwong N, Wu Y, Ryu E, Hecker LA, Baratz KH, Brown WL, Edwards AO.
ARVO Annual Meeting, Mai 2011, Fort Lauderdale.
Analysis of Choroidal Vasculature and Thickness in Retinal Pathologies using 1060nm OCT
Esmaeelpour M, Povazay B, Hermann B, Kajic V, Schmid-Kubista K, Stolba U, Krebs I, Ansari Shahrezaei S, Kellner L, Binder S, Drexler W.
ARVO/ISIE Imaging Conference, April 2011, Fort Lauderdale.
Copy Number Variation at the CFHR3/CFHR1 Locus Has a Major Impact on AMD Risk That Is Independent of the Effect of the Histidine Risk Allele at CFH Y402H
Schmid-Kubista KE, Tosakulwong N, Ryu E, Wu Y, Baratz KH, Brown WL, Hecker LA, Roeder JL, Edwards AO.
ARVO Annual Meeting, Mai 2009, Fort Lauderdale.
UV-Belastung bei der bäuerlichen Arbeit
Maier H, Schmalwieser A, Rohn H, Kellner L, Wanka A, El Modeir A, Felke S, Schmid-Kubista KE, Schmidt JB, Cabaj A, Stadelmann H, Spiess J, Binder S, Fischer W, Hönigsmann H.
Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venereologie, November 2008, Wien.
Veränderungen von Endothelstammzellen bei diabetischer Retinopathie
Hoellerl F, Brunner S, Satler M, Elhenicky M, Schmid-Kubista KE, Zeiler F, Binder S, Schernthaner G, Schernthaner GH.
Angio & Phlebo Meeting, November 2008, Wien.
Systemic Bevacizumab Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study).
Schmid-Kubista KE, Krebs I, Gruenberger B, Schueller J, Binder S.
Invest Ophthalmol Vis Sci 2008 49: E-Abstract 304. ARVO Annual Meeting, April 2008, Fort Lauderdale.
Chlamydia Pneumoniae Infection and Complement Factor H Gene Polymorphism in Age-Related Macular Degeneration – Is There an Association?
Haas P, Aggermann T, Schmid-Kubista KE, Steindl K, Krugluger W, Binder S.
Invest Ophthalmol Vis Sci 2008 49: E-Abstract 1358. ARVO Annual Meeting, April 2008, Fort Lauderdale.
UV-Belastung österreichischer Landwirte: Epidemiologische Untersuchung und dosimetrischer Feldversuch.
Maier H, Schmalwieser A, Rohn H, Kellner L, Wanka A, El Modeir A, Felke S, Schmid K, Schmidt J, Cabaj A, Binder S, Fischer W, Hönigsmann H.
9. Tagung der Arbeitsgemeinschaft für Berufs- und Umweltdermatologie (ABD), Oktober 2007, Berlin, Deutschland.
Y402H complement factor H polymorphism and age-related macular degeneration in the Austrian population.
Haas P, Steindl K, Schmid-Kubista KE, Krugluger W, Binder S.
Ocular Cell & Molecular Biology (OCMB), September 2007, Sarasota, Florida, USA.
Extracorporal rheohaemapheresis for age-related macular degeneration: preliminary experience in 4 patients.
Schmid KE, Worel N, Hoecker P, Binder S.
Joint Congress of SOE / AAO, June 2007, Vienna, Austria.
Comparison of Visual Fields After Membrane Blue or Indocyanine Green Staining in Vitreoretinal Surgery.
Schmid KE, Lamar PD, Stolba U, Binder S.
Joint Meeting of the American Academy of Ophthalmology (AAO) and the Asia Pacific Academy of Ophthalmology (APAO), November 2006, Las Vegas, Nevada, USA.
Rheohaemapheresis for Age Related Macular Degeneration: Preliminary Experience in 4 Patients.
Worel N, Schmid KE, Leitner G, Binder S, Höcker P.
39. Jahreskongress der deutschen Gesellschaft für Transfusionsmedizin und Imunhämatologie (DGTI), September 2006, Frankfurt am Main.
Auswirkungen berufsbedingter Sonnenexposition auf Augenveränderungen bei Landwirten in Österreich - Die SVB- UV Studie.
Kellner LM, Felke S, Schmid KE, Wanka A, EL Modeir A, Maier H, Binder S.
47. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2006, Stift Göttweig.
Natural Course of Intraocular Pressure after Cataract Surgery with Viscoat.
Schmid K, Menapace R, Findl O, Sacu S, Kiss B, Petternel V, Bühl W, Georgopoulos M, Rainer G.
XXth Congress of the European Society for Cataract and Refractive Surgery (ESCRS), September 2001, Amsterdam
Verlauf des frühpostoperativen Augeninnendruckes nach Kleinschnittkataraktchirurgie: Healon vs. Ocucoat.
Rainer G, Schmid K, Menapace R, Findl O, Sacu S, Bühl W, Petternel V.
43. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2002, Graz.
Verlauf des frühpostoperativen Augeninnendruckes nach Kleinschnittkataraktchirurgie mit Viscoat.
Rainer G, Menapace R, Findl O, Schmid K, Sacu S, Kiss B, Petternel V.
43. Tagung der Österreichischen Ophthalmologischen Gesellschaft (ÖOG), Mai 2002, Graz.
Verlauf des frühpostoperativen Augeninnendruckes nach Kleinschnittkataraktchirurgie: Healon vs. Ocucoat.
Rainer G, Schmid K, Menapace R, Findl O, Sacu S, Bühl W, Petternel V.
15. Kongress der Deutschen Ophthalmochirurgen (DOC), Juni 2002, Nürnberg.
Preliminary Results of a Multicenter Phase II Trial Investigating Two Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
Scheithauer W, Kornek GV, Schmid K, Raderer M, Lenauer A, Depisch D, Lang F, Schneeweiss B, Längle F.
EFMO, Oktober 2002, Nizza.
Mitomycin C in Combination with Capecitabine or Biweekly High Dose Gemcitabine in Patients with Advanced Bilary Tract Cancer: Preliminary Results of a Parallel Phase II Trial.
Kornek GV, Schmid K, Schuell B, Raderer M, Kwasny W, Haider K, Depisch D, Lang F, Scheithauer W.
EFMO, Oktober 2002, Nizza.
Biweekly High Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Scheithauer W, Schüll B, Ulrich-Pur H, Schmid K, Raderer M, Haider K, Kwasny W, Depisch D, Schneeweiss B, Lang F, Kornek G.
EORTC Symposium on Gastrointestinal, Liver and Pancreatic Cancer, Juni 2002, Venedig.
Intermittent Weekly High-Dose Capecitabine in Combination with Oxaliplatin: A Phase I / II Study in First-Line Treatment of Patients with Advanced Colorectal Cancer.
Kornek G, Schüll B, Schmid K, Raderer M, Längle F, Scheithauer W.
EORTC Symposium on Gastrointestinal, Liver and Pancreatic Cancer, Juni 2002, Venedig.
Biweekly High Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Scheithauer W, Schüll B, Ulrich-Pur H, Schmid K, Raderer M, Haider K, Kwasny W, Depisch D, Schneeweiss B, Lang F, Kornek G.
American Society of Clinical Oncology, Mai 2002, Orlando.
Biweekly High Dose Gemcitabine Alone or in Combination with Capecitabine in Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Kornek G, Schüll B, Ulrich-Pur H, Raderer M, Schmid K, Schneeweiss B, Lang F, Haider K, Kwasny W, Depisch D, Scheithauer W.
12. International Congress of Anti-Cancer Treatment, Februar 2002, Paris.
Intermittent Weekly High-Dose Capecitabine in Combination with Oxaliplatin: A Phase I / II Study in First-Line Treatment of Patients with Advanced Colorectal Cancer.
Scheithauer W, Kornek G, Raderer M, Schüll B, Schmid K, Längle F, Huber H.
12. International Congress of Anti-Cancer Treatment, Februar 2002, Paris.